Abbott Labs (ABT) completes the separation of AbbVie (ABBV), its R&D-based pharmaceuticals business that will start trading on the NYSE today. Wells Fargo maintains an "Outperform" rating on Abbott's ...
Abbott Labs ( ABT ) completes the separation of AbbVie ( ABBV ), its R&D-based pharmaceuticals business that will start trading on the NYSE today. Wells Fargo maintains an " Outperform " rating on Abbott's shares, citing the company's above-average growth outlook and opportunities to significantly ...
Read the rest of this article on SeekingAlpha.com: SA Currents
Related Videos
-
Wells Fargo Succeeds by Keeping It SimpleWells Fargo does a good job of executing the old banking mantra: pay depositors 3%, lend at 6%, and be on the golf course by 3 p.m.
-
Dorsey: Two Simple Reasons to Own Wells FargoTwo advantages and a compelling valuation make this bank worth holding, says Morningstar's director of equity research.